27 completed, 8 recruiting, 8 unknown, 4 active not recruiting. 18 Not applicable, 9 Phase 4, 6 Phase 2, 6 Phase 3, 5 Phase 1.
Follow Vaccine-Preventable Diseases: new trials by email Literature Review of Vaccine-Preventable Diseases trials Research Report on Vaccine-Preventable Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-center, Open-label Study: Immunogenicity and Safety Observation After Vaccination With ACYW135 Meningococcal Polysaccharide Vaccine in Junior High School Students Aged 13-15 Years MPSV-ACYW - Meningococcal Disease; Meningococcal Meningitis | Phase 4 | Not yet recruiting | Zhejiang Provincial Center for Disease Control and Prevention | 200 | 2026-10-20 | 2026-10-21 |
| Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old Maternal TdaP2gen vaccine, Infant Acellular Pertussis-containing Vaccine, Infant Whole-cell Pertussis-containing Vaccine - Pertussis, Diphtheria | Phase 4 | Not yet recruiting | Chiang Mai University | 320 | 2026-05-26 | 2026-06-02 |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Playing Game to Learn About Children's Vaccine Project vaccination game - HPV, Vaccine-Preventable Diseases | Not applicable | Recruiting | Michigan State University | 180 | 2025-10-27 | 2026-05-20 |
| Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies Co-payment Model - Step 1, Co-payment Model - Step 2, Co-payment Model - Step 3 - Preventable Disease, Vaccine | Not applicable | Recruiting | Canadian Immunization Research Network | 600 | 2025-10-23 | 2026-03-19 |
| Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents Hepatitis A, Hepatitis A Virus | Active not recruiting | Chiang Mai University | 60 | 2025-06-26 | 2026-05-22 | |
| Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV Inactivated hepatitis A vaccine (I-HAV) - Hepatitis A, Hepatitis A Virus | Phase 3 | Active not recruiting | Chiang Mai University | 36 | 2025-05-25 | 2026-05-22 |
| Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836 OVX836 shot - Vaccine-Preventable Diseases, Influenza | Phase 2 | Completed | Osivax | 117 | 2024-10-22 | 2025-06-06 |
| Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States protein subunit: Novavax COVID-19 vaccine, Pfizer mRNA COVID-19 vaccine - COVID-19, Vaccine-Preventable Diseases | Phase 4 | Completed | Novavax | 660 | 2024-09-19 | 2026-06-02 |
| Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over Z-1018, Shingrix - Shingles, Herpes Zoster | Phase 1 / Phase 2 | Active not recruiting | Dynavax Technologies Corporation | 764 | 2024-06-17 | 2026-10-16 |
| Collaborative Open Research Initiative Study (CORIS-1) No intervention. This is an observational study - Patient Engagement, COVID-19 | Unknown | Chisquares Incorporated | 15000 | 2024-06-01 | 2024-04-10 | |
| Vaccine Hesitancy in Patients with Solid Tumors: a Cross-sectional Single-center Survey Cancer Patients, Vaccine-Preventable Diseases | Completed | Fondazione IRCCS Policlinico San Matteo di Pavia | 309 | 2024-05-31 | 2025-03-17 | |
| Culturally Tailored HPV Psychoeducational Multimedia Intervention Culturally Tailored Multimedia Psychoeducational HPV Intervention, General HPV Multimedia Psychoeducational Control Group - Health Knowledge, Attitudes, Practice, Vaccine-Preventable Diseases | Not applicable | Completed | University of Texas, El Paso | 63 | 2024-05-02 | 2026-08-21 |
| Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents Mevac-A vaccine, Havrix 720 Junior - HAV, Hepatitis A | Phase 3 | Completed | Chiang Mai University | 120 | 2024-04-27 | 2025-05-04 |
| Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters Immersive resident education, Standardized patient (SP) encounter - Vaccine Refusal, Vaccine-Preventable Diseases | Not applicable | Completed | Corewell Health East | 112 | 2024-04-25 | 2026-01-22 |
| Game-Based Intervention to Promote HPV Vaccination HPV game - HPV Infection, Vaccine-Preventable Diseases | Not applicable | Completed | Michigan State University | 133 | 2024-04-01 | 2026-05-20 |
| Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years. UVAX-1107, UVAX-1197, Placebo - AIDS/HIV - RelatedDisease Associated With AIDS, Vaccine-Preventable Diseases | Early Phase 1 | Completed | Uvax Bio LLC | 34 | 2024-01-30 | 2025-05-23 |
| Animal Bite Victims Seeking Medical Services at Concerned Hospitals health seeking behavior - Vaccine-Preventable Diseases | Not yet recruiting | Assiut University | 662 | 2024-01-01 | 2023-09-26 | |
| Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents Baseline surveys, Digital Storytelling Intervention, Information Control Intervention - Vaccine-Preventable Diseases, COVID-19 Pandemic | Not applicable | Completed | Arizona State University | 80 | 2023-12-01 | 2026-01-26 |
| The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection Novavax COVID-19 vaccine (2023-2024 formula XBB containing), Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing) - COVID-19, Vaccine-Preventable Diseases | Phase 4 | Completed | Sarang K. Yoon, DO, MOH | 1188 | 2023-11-22 | 2026-01-28 |
Showing 20 of 52. Sign in to see all of them.
COVID-19 (10) · Herpes Zoster (6) · Hepatitis A (4) · Vaccination Hesitancy (4) · Whooping Cough (4) · Influenza, Human (3) · Patient Acceptance of Health Care (3) · Behavior (2) · Chickenpox (2) · Encephalitis, Japanese (2) · Health Behavior (2) · Hepatitis (2) · Hepatitis B (2) · Measles (2)
Infections (51) · Virus Diseases (29) · RNA Virus Infections (19) · Respiratory Tract Diseases (16) · Respiratory Tract Infections (15) · DNA Virus Infections (11) · Lung Diseases (11) · Coronaviridae Infections (10) · Coronavirus Infections (10) · Nidovirales Infections (10) · Pneumonia (10) · Pneumonia, Viral (10) · Bacterial Infections (8) · Bacterial Infections and Mycoses (8) · Treatment Adherence and Compliance (8)
heterologous prime boost COVID-19 vaccination (2) · 2019-nCoV Vaccine mRNA-1273 (1) · BCG Vaccine (1) · BNT162 Vaccine (1) · ChAdOx1 nCoV-19 (1) · Cholera Vaccines (1) · Dukoral (1) · Engerix-B (1) · FHD (1) · Hepatitis B Vaccines (1) · Influenza Vaccines (1) · Japanese Encephalitis Vaccines (1) · Measles Vaccine (1) · NMT1 protein, S pombe (1) · NVX-CoV2373 adjuvated lipid nanoparticle (1)
Chiang Mai University (4) · Dynavax Technologies Corporation (3) · Aribio Lab Co., Ltd. (2) · Bandim Health Project (2) · Beijing Luzhu Biotechnology Co., Ltd. (2) · Children's Hospital Medical Center, Cincinnati (2) · Michigan State University (2) · Zhejiang Provincial Center for Disease Control and Prevention (2) · Arizona State University (1) · Assiut University (1) · Canadian Immunization Research Network (1) · Chisquares Incorporated (1) · Corewell Health East (1) · Federal University of Espirito Santo (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1)
United States (16) · Thailand (4) · Australia (3) · Canada (3) · China (2) · Denmark (2) · Netherlands (2) · South Korea (2) · Belgium (1) · Brazil (1) · Cambodia (1) · Finland (1) · France (1) · Guinea-Bissau (1) · Hong Kong (1)
Tavitiya Sudjaritruk, MD, PhD (4) · Natchaya Kunanitthaworn, MD (3) · Alexis Koskan, Ph.D (1) · Andrea C Hernandez Troya, MD (1) · Anna Vlasova (1) · Anne Marie Rosendahl Madsen, MD (1) · Annemette Hald, RN (1) · Anu Kantele, MD, PhD (1) · Carsten S Larsen, MD, DMSc (1) · Christine Benn, DMSc (1)
PMID 25748976, PMID 29502522, PMID 36202236, PMID 37600800, PMID 37781954, PMID 37833325, PMID 37845608, PMID 39423874, PMID 41276263, PMID 41592795, PMID 41746039, PMID 42042812, PMID 42811742
OT2HL158287 (1), R01CA229324 (1), R21HD110837 (1), U54MD007592 (1)